<DOC>
	<DOCNO>NCT00713609</DOCNO>
	<brief_summary>Benzoyl peroxide , clindamycin tazarotene know effective treatment alternative acne vulgaris . The purpose study assess safety efficacy combination product include active treatment acne vulgaris . You may suitable take part study acne vulgaris face . Acne vulgaris usually affect face , also affect skin chest , arm , leg , back .</brief_summary>
	<brief_title>Safety Efficacy Study Clindamycin/Benzoyl Peroxide/Tazarotene Cream Subjects With Acne</brief_title>
	<detailed_description>The study subject must acne vulgaris apply study drug face 12 week . Study visit occur baseline ( day 1 ) week 2 , 4 , 8 , 12 . Subjects assess every visit determine study drug work . Safety assess evaluation adverse event ( AEs ) , vital sign , physical examination , withdrawal study .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Tazarotene</mesh_term>
	<mesh_term>Benzoyl Peroxide</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Subjects must males female 12 45 year age . Subjects must acne face . Female subject childbearing potential must negative pregnancy test . If sexually active , one medically acceptable form contraception must practice baseline last study visit . Subjects must ability willingness follow study procedure , attend schedule visit , successfully complete study . Subjects must capable understand willing provide sign dated write voluntary inform consent ( local national authorization requirement ) . Subjects must able complete study comply study instruction . Subjects pregnant , try become pregnant , breastfeed . Subjects condition may influence safety efficacy assessment study include , limited : regional enteritis inflammatory bowel disease , lupus , dermatomyositis , rosacea , seborrheic dermatitis , beard folliculitis , perioral dermatitis , subject immunocompromised major illness within 30 day screen examination History know suspect intolerance include know hypersensitivity previous allergic reaction ingredient study product Subjects use topical antibiotic topical steroid face , facial procedure , investigational therapy within past 4 week systemic retinoids within past 6 month . Subjects disease condition , use medication , judgment investigator would put subject unacceptable risk participation study . Other exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Acne</keyword>
	<keyword>Acne Vulgaris</keyword>
	<keyword>Pimples</keyword>
</DOC>